Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mari-Anne Gall

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Clinical Chemistry|September 20, 2011
Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetesClaudia Cangemi, Vibe Skov, Michael Kjaer Poulsen, et al.
Diabetologia|July 22, 2024
Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trialsJoseph Mellor, Dmitry Kuznetsov, Simon Heller, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Clinical Chemistry|September 20, 2011
Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetesClaudia Cangemi, Vibe Skov, Michael Kjaer Poulsen, et al.
Diabetologia|July 22, 2024
Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trialsJoseph Mellor, Dmitry Kuznetsov, Simon Heller, et al.
Pageof 3